Comparing Genvoya vs Triumeq
| Genvoya | Triumeq |
|
|---|
| Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) | Triumeq (abacavir / dolutegravir / lamivudine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Genvoya is a combination antiviral medication that also includes a pharmacokinetic enhancer that can be used to treat people and children with HIV-1 who meet certain criteria. It is 84% to 93%... View more |
Prescription only
Triumeq is a fixed-dose combination tablet that contains three antivirals: abacavir, dolutegravir, and lamivudine, which may be used to treat HIV-1 infection in adults and children weighing at least... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
| More about Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) | More about Triumeq (abacavir / dolutegravir / lamivudine) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Genvoya has an average rating of 7.2 out of 10 from a total of 123 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 20% reported a negative effect. |
Triumeq has an average rating of 8.3 out of 10 from a total of 119 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Genvoya side effects in more detail. |
See also: Triumeq side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Genvoya prices |
View all Triumeq prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other abacavir / dolutegravir / lamivudine brands include: Triumeq PD | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
17 hours |
14 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 634 drugs are known to interact with Genvoya:
|
A total of 198 drugs are known to interact with Triumeq:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
August 22, 2014 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.